Chief Investment Officer of Scientia Capital, a specialized global investment fund focused exclusively on life sciences​.

​

Prior to this, Lawrence was responsible for the largest biotechnology investment portfolio in Australia as the institutional biotechnology analyst at Queensland Investment Corporation, an investment fund managing over AU$60 billion.